Hillsdale Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-914
| Closed | -$20.1K | – | 702 |
|
|
2024
Q4 | $20.1K | Hold |
914
| – | – | ﹤0.01% | 463 |
|
|
2024
Q3 | $16.5K | Buy |
914
+254
| +38% | +$4.58K | ﹤0.01% | 479 |
|
|
2024
Q2 | $10.7K | Buy |
+660
| New | +$10.7K | ﹤0.01% | 479 |
|
|
2016
Q1 | – | Sell |
-6,080
| Closed | -$399K | – | 547 |
|
|
2015
Q4 | $399K | Sell |
6,080
-1,200
| -16% | -$78.8K | 0.15% | 138 |
|
|
2015
Q3 | $411K | Buy |
7,280
+1,380
| +23% | +$77.9K | 0.14% | 139 |
|
|
2015
Q2 | $349K | Sell |
5,900
-100
| -2% | -$5.92K | 0.11% | 185 |
|
|
2015
Q1 | $374K | Buy |
6,000
+2,000
| +50% | +$125K | 0.1% | 189 |
|
|
2014
Q4 | $230K | Sell |
4,000
-1,000
| -20% | -$57.5K | 0.06% | 304 |
|
|
2014
Q3 | $269K | Buy |
+5,000
| New | +$269K | 0.09% | 225 |
|